The latest report published by IMARC Group, titled, “Contraceptive Devices Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2028″, offers a comprehensive analysis of the industry, which comprises insights on the global contraceptive devices market report. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The global contraceptive devices market size reached US$ 13.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 19.0 Billion by 2028, exhibiting a growth rate (CAGR) of 5.3% during 2023-2028.
Contraceptive Devices Market Overview:
Contraceptive devices are medical products specifically engineered to prevent unintended pregnancies. These devices offer a reliable method for family planning and birth control, and they come in various types, such as intrauterine devices (IUDs), condoms, diaphragms, and contraceptive implants. Each type serves the primary purpose of preventing sperm from meeting an egg, thereby averting conception. These devices are highly advantageous as they offer immediate reversibility long-term efficacy, and can also provide additional health benefits like menstrual regulation and reducing the risk of certain reproductive infections. Commonly used by individuals and couples of reproductive age, contraceptive devices play a critical role in reproductive health, providing a way to manage fertility responsibly and effectively.
Get a Sample Copy of the Report at: https://www.imarcgroup.com/contraceptive-devices-market/requestsample
Global Contraceptive Devices Market Trends:
The global market is majorly driven by the growing awareness about family planning and reproductive health, especially in developing countries. Along with this, increased educational programs and public awareness campaigns are leading to a wider acceptance and adoption of these devices. Additionally, continuous advancements in technology have resulted in the development of more effective and user-friendly devices, further accelerating market adoption. Pharmaceutical companies are also investing in research and development to promote cutting-edge products. Moreover, the increasing focus on women’s health and empowerment contributes to the upward trend in the usage of contraceptive devices.
Governments and non-governmental organizations are partnering to make these devices more accessible, thus broadening the market scope. Another influential factor is the introduction of hormone-free and non-invasive contraceptive devices, which are appealing to individuals who are concerned about the side effects of hormonal methods. All these drivers collectively contribute to the robust growth of the global contraceptive devices market, making it a lucrative area for investment and innovation.
Explore the Full Report with Charts, Table of Contents, and List of Figures: https://www.imarcgroup.com/contraceptive-devices-market
Key Market Segmentation:
Competitive Landscape with Key Players:
- Allergan Plc
- Bayer Healthcare
- Church Dwight Co. Inc.
- Cooper Surgical Inc.
- Merck Co.
- Mylan Laboratories
- Pfizer Inc.
- Reckitt Benckiser
- Teva Pharmaceutical Industries Ltd.
- The Female Health Company
Breakup by Device Type:
- Condoms
- Diaphragms
- Cervical Caps
- Sponges
- Vaginal Rings
- IUDs
- Others
Breakup by End User:
- Male
- Female
Breakup by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Stores
- Others
Breakup by Application:
- Household
- Commercial
- Others
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key Highlights of the Report:
- Market Performance
- Market Outlook
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145
